↓ Skip to main content

The Mechanisms and Applications of T Cell Vaccination for Autoimmune Diseases: a Comprehensive Review

Overview of attention for article published in Clinical Reviews in Allergy & Immunology, August 2014
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (86th percentile)
  • Good Attention Score compared to outputs of the same age and source (66th percentile)

Mentioned by

twitter
13 X users
patent
1 patent
facebook
4 Facebook pages
googleplus
1 Google+ user

Citations

dimensions_citation
21 Dimensions

Readers on

mendeley
53 Mendeley
Title
The Mechanisms and Applications of T Cell Vaccination for Autoimmune Diseases: a Comprehensive Review
Published in
Clinical Reviews in Allergy & Immunology, August 2014
DOI 10.1007/s12016-014-8439-6
Pubmed ID
Authors

Xin Huang, Haijing Wu, Qianjin Lu

Abstract

Autoimmune diseases (ADs) are a spectrum of diseases originating from loss of immunologic self-tolerance and T cell abnormal autoreactivity, causing organ damage and death. However, the pathogenic mechanism of ADs remains unclear. The current treatments of ADs include nonsteroidal anti-inflammatory drugs (NSAIDS), antimalarials, corticosteroids, immunosuppressive drugs, and biological therapies. With the need to prevent side effects resulting from current treatments and acquire better clinical remission, developing a novel pharmaceutical treatment is extremely urgent. The concept of T cell vaccination (TCV) has been raised as the finding that immunization with attenuated autoreactive T cells is capable of inducing T cell-dependent inhibition of autoimmune responses. TCV may act as an approach to control unwanted adaptive immune response through eliminating the autoreactive T cells. Over the past decades, the effect of TCV has been justified in several animal models of autoimmune diseases including experimental autoimmune encephalomyelitis (EAE), murine autoimmune diabetes in nonobese diabetic (NOD) mice, collagen-induced arthritis (CIA), and so on. Meanwhile, clinical trials of TCV have confirmed the safety and efficacy in corresponding autoimmune diseases ranging from multiple sclerosis (MS) to systemic lupus erythematosus (SLE). This review aims to summarize the ongoing experimental and clinical trials and elucidate possible molecule mechanisms of TCV.

X Demographics

X Demographics

The data shown below were collected from the profiles of 13 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 53 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Spain 2 4%
Unknown 51 96%

Demographic breakdown

Readers by professional status Count As %
Researcher 14 26%
Student > Ph. D. Student 11 21%
Student > Master 6 11%
Student > Bachelor 4 8%
Other 4 8%
Other 6 11%
Unknown 8 15%
Readers by discipline Count As %
Medicine and Dentistry 19 36%
Agricultural and Biological Sciences 10 19%
Biochemistry, Genetics and Molecular Biology 4 8%
Neuroscience 3 6%
Immunology and Microbiology 3 6%
Other 4 8%
Unknown 10 19%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 11. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 21 January 2016.
All research outputs
#3,121,994
of 23,975,976 outputs
Outputs from Clinical Reviews in Allergy & Immunology
#115
of 690 outputs
Outputs of similar age
#31,422
of 233,945 outputs
Outputs of similar age from Clinical Reviews in Allergy & Immunology
#4
of 12 outputs
Altmetric has tracked 23,975,976 research outputs across all sources so far. Compared to these this one has done well and is in the 86th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 690 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.8. This one has done well, scoring higher than 83% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 233,945 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 86% of its contemporaries.
We're also able to compare this research output to 12 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 66% of its contemporaries.